Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Healthcare Corp, Raqualia Pharma IncfiledCriticalCj Healthcare Corp
Priority to ARP170103435ApriorityCriticalpatent/AR110330A1/en
Publication of AR110330A1publicationCriticalpatent/AR110330A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Reivindicación 1: Una composición farmacéutica para la prevención o el tratamiento del escape ácido nocturno, que comprende: un compuesto representado por la fórmula química (1), dada a continuación, o una sal farmacéuticamente aceptable del mismo, como ingrediente activo.Claim 1: A pharmaceutical composition for the prevention or treatment of night acid leakage, comprising: a compound represented by the chemical formula (1), given below, or a pharmaceutically acceptable salt thereof, as active ingredient.
ARP170103435A2017-12-072017-12-07
USE OF BENCIMIDAZOL DERIVATIVES FOR NIGHT ACID EXHAUST
AR110330A1
(en)
COMPOUNDS DERIVED FROM N- (1,5-DIMETHYL-3-OXO-2,3-DIHYDRO-1H-PIRAZOL-4-IL) -4-METHYL-5-ISOXAZOLE-3-CARBOXAMIDE ACTIVE AS SELECTIVE INHIBITORS OF SMURF-1